Nerandomilast, a PDE4B inhibitor, is a new treatment option for IPF, showing better tolerability than nintedanib and ...
When doctors biopsy and treat cancer may be just as important as how they treat it. New research from Erik Herzog, Ph.D., the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback